ROFECOXIB ASSOCIATED WITH A WEEKLY SCHEDULE OF IRINOTECAN AND INFUSIONAL 5-FLUOROURACIL AS SECOND-LINE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER: RESULTS OF A PHASE I–II STUDY


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles